ES2187056T3 - Producto que comprende al menos un arn bicatenario en asociacion con al menos un derivado del 6-bencil-uracilo para una utilizacion terapeutica simultanea, separada o distribuida en el tiempo. - Google Patents
Producto que comprende al menos un arn bicatenario en asociacion con al menos un derivado del 6-bencil-uracilo para una utilizacion terapeutica simultanea, separada o distribuida en el tiempo.Info
- Publication number
- ES2187056T3 ES2187056T3 ES98941526T ES98941526T ES2187056T3 ES 2187056 T3 ES2187056 T3 ES 2187056T3 ES 98941526 T ES98941526 T ES 98941526T ES 98941526 T ES98941526 T ES 98941526T ES 2187056 T3 ES2187056 T3 ES 2187056T3
- Authority
- ES
- Spain
- Prior art keywords
- product
- derivative
- uracilo
- bicatenary
- bencil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
La invención se refiere a un producto que comprende al menos un ARN de doble hebra combinado con al menos un derivado de 6-benciluracilo para una utilización terapéutica simultánea, separada o extendida en el tiempo. Dicho producto se puede combinar opcionalmente con otro agente antiviral. Dichos productos son particularmente útiles para tratar el SIDA (Síndrome de Inmunodeficiencia Adquirida).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9709974A FR2766711B1 (fr) | 1997-08-04 | 1997-08-04 | Produit comprenant au moins un arn double brin en association avec au moins un devire du 6-benzyluracile pour une utilisation therapeutique simultanee, separee ou etalee dans le temps |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2187056T3 true ES2187056T3 (es) | 2003-05-16 |
Family
ID=9510012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98941526T Expired - Lifetime ES2187056T3 (es) | 1997-08-04 | 1998-08-03 | Producto que comprende al menos un arn bicatenario en asociacion con al menos un derivado del 6-bencil-uracilo para una utilizacion terapeutica simultanea, separada o distribuida en el tiempo. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1001789B1 (es) |
AT (1) | ATE227132T1 (es) |
AU (1) | AU8987198A (es) |
DE (1) | DE69809246T2 (es) |
DK (1) | DK1001789T3 (es) |
ES (1) | ES2187056T3 (es) |
FR (1) | FR2766711B1 (es) |
NO (1) | NO20000554D0 (es) |
PT (1) | PT1001789E (es) |
WO (1) | WO1999007384A1 (es) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950652A (en) * | 1987-03-23 | 1990-08-21 | Hem Research, Inc. | dsRNAs for combination therapy in the treatment of viral diseases |
-
1997
- 1997-08-04 FR FR9709974A patent/FR2766711B1/fr not_active Expired - Fee Related
-
1998
- 1998-08-03 DE DE69809246T patent/DE69809246T2/de not_active Expired - Fee Related
- 1998-08-03 ES ES98941526T patent/ES2187056T3/es not_active Expired - Lifetime
- 1998-08-03 DK DK98941526T patent/DK1001789T3/da active
- 1998-08-03 EP EP98941526A patent/EP1001789B1/fr not_active Expired - Lifetime
- 1998-08-03 AT AT98941526T patent/ATE227132T1/de not_active IP Right Cessation
- 1998-08-03 WO PCT/FR1998/001726 patent/WO1999007384A1/fr active IP Right Grant
- 1998-08-03 AU AU89871/98A patent/AU8987198A/en not_active Abandoned
- 1998-08-03 PT PT98941526T patent/PT1001789E/pt unknown
-
2000
- 2000-02-03 NO NO20000554A patent/NO20000554D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1001789A1 (fr) | 2000-05-24 |
DE69809246D1 (de) | 2002-12-12 |
NO20000554L (no) | 2000-02-03 |
EP1001789B1 (fr) | 2002-11-06 |
NO20000554D0 (no) | 2000-02-03 |
FR2766711A1 (fr) | 1999-02-05 |
PT1001789E (pt) | 2003-03-31 |
AU8987198A (en) | 1999-03-01 |
FR2766711B1 (fr) | 2001-02-02 |
WO1999007384A1 (fr) | 1999-02-18 |
ATE227132T1 (de) | 2002-11-15 |
DE69809246T2 (de) | 2003-08-28 |
DK1001789T3 (da) | 2003-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2171039T3 (es) | Producto que comprende al menos un rna bicatenario en asociacion con al menos un interferon para el tratamiento de la hepatitis viral. | |
NO985643L (no) | Antimikrobielle blandinger | |
DK1036058T3 (da) | Adamantanderivater | |
DK1036059T3 (da) | Adamantanderivater | |
MX9204625A (es) | Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva. | |
ES2145774T3 (es) | Derivados de adenosina que tienen actividad agonista en a2. | |
AP2000001942A0 (en) | Use of organophosphoric compounds for the therapeutic and preventative treatment of infections. | |
PT703786E (pt) | Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida | |
ES2157422T3 (es) | Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos. | |
MY138883A (en) | Use of asiatic acid for treatment of cencer | |
DE59902006D1 (de) | Wirkstoffhaltige aromatische copolyester | |
BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
ES2188995T3 (es) | Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales. | |
NZ524936A (en) | Methods of inducing cancer cell death and tumor regression using a FTP inhibitor and a tyrosine kinase inhibitor | |
ES2172171T3 (es) | Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles. | |
MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
AU2672099A (en) | Compositions and methods for wound healing | |
AR029451A1 (es) | Una composicion para su uso en la terapia del cancer de mamas en seres humanos y un producto para su uso en dicha terapia | |
MX9203405A (es) | Compuestos activos para usarse en el tratamiento de tumores. | |
ES2194104T3 (es) | Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos. | |
ES2187056T3 (es) | Producto que comprende al menos un arn bicatenario en asociacion con al menos un derivado del 6-bencil-uracilo para una utilizacion terapeutica simultanea, separada o distribuida en el tiempo. | |
HUP0204208A2 (hu) | Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény | |
CA2003213A1 (en) | Antimycotically active cyclopropyl-substituted azolylmethylcarbinols | |
MX9201258A (es) | Compuestos para el tratamiento del cancer y procedimiento para su preparacion. | |
DK0980379T3 (da) | Chimære oligonucleotider og deres anvendelse |